E. Roberts

4.4k total citations
78 papers, 3.4k citations indexed

About

E. Roberts is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, E. Roberts has authored 78 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 25 papers in Molecular Biology and 19 papers in Physiology. Recurrent topics in E. Roberts's work include Neuroscience and Neuropharmacology Research (28 papers), Biochemical effects in animals (15 papers) and GABA and Rice Research (14 papers). E. Roberts is often cited by papers focused on Neuroscience and Neuropharmacology Research (28 papers), Biochemical effects in animals (15 papers) and GABA and Rice Research (14 papers). E. Roberts collaborates with scholars based in United States, Japan and United Kingdom. E. Roberts's co-authors include John E. Morley, James F. Flood, J.‐Y. Wu, James E. Vaughn, Charles E. Ribak, Kengo Kuriyama, Silvio Varon, Harel Weinstein, Arne Schousboe and B. Haber and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

E. Roberts

75 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Roberts United States	29	1.9k	1.4k	680	435	392	78	3.4k
Theodore L. Sourkes Canada	40	2.0k 1.1×	1.6k 1.1×	814 1.2×	328 0.8×	119 0.3×	258	5.5k
A. William Tank United States	30	1.4k 0.7×	1.1k 0.8×	577 0.8×	331 0.8×	267 0.7×	57	3.1k
Masaomi Miyamoto Japan	35	1.8k 0.9×	1.9k 1.4×	761 1.1×	269 0.6×	128 0.3×	111	5.2k
John F. Tallman United States	38	3.7k 2.0×	3.0k 2.2×	1.0k 1.5×	336 0.8×	222 0.6×	92	6.0k
Nobuyoshi Nishiyama Japan	39	1.9k 1.0×	1.6k 1.1×	603 0.9×	419 1.0×	427 1.1×	131	4.6k
Kinya Kuriyama Japan	36	2.1k 1.1×	1.5k 1.1×	1.2k 1.7×	107 0.2×	316 0.8×	192	4.1k
V. Gene Erwin United States	31	1.9k 1.0×	2.0k 1.5×	1.0k 1.5×	171 0.4×	108 0.3×	101	4.5k
David Sugden United Kingdom	45	2.2k 1.2×	2.4k 1.8×	1.0k 1.5×	155 0.4×	207 0.5×	149	6.8k
G. Toffano Italy	40	3.4k 1.8×	2.9k 2.1×	863 1.3×	249 0.6×	111 0.3×	170	6.0k
F.V. DeFeudis France	29	1.7k 0.9×	1.2k 0.9×	870 1.3×	122 0.3×	268 0.7×	196	3.4k

Countries citing papers authored by E. Roberts

Since Specialization

Citations

This map shows the geographic impact of E. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Roberts more than expected).

Fields of papers citing papers by E. Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Roberts. The network helps show where E. Roberts may publish in the future.

Co-authorship network of co-authors of E. Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of E. Roberts. A scholar is included among the top collaborators of E. Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Roberts. E. Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roberts, E., et al.. (2024). EPS8.03 Impact of 12 months of elexacaftor/tezacaftor/ivacaftor on pulmonary function and exercise capacity in patients with cystic fibrosis. Journal of Cystic Fibrosis. 23. S57–S57.

Sun, Caixia, Mina S. Sedrak, Marwan Fakih, et al.. (2019). PATIENT-DEFINED PREFERENCES AND HEALTH OUTCOME PRIORITIZATION AMONG OLDER ADULTS WITH CANCER STARTING CHEMOTHERAPY. Journal of Geriatric Oncology. 10(6). S27–S27. 1 indexed citations

Wolkowitz, Owen M., Joel H. Kramer, Victor I. Reus, et al.. (2003). DHEA treatment of Alzheimer’s disease. Neurology. 60(7). 1071–1076. 72 indexed citations

Guth, Lloyd, et al.. (1994). Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury.. Proceedings of the National Academy of Sciences. 91(25). 12308–12312. 93 indexed citations

Reus, Victor I., et al.. (1994). Dehydroepiandrosterone (DHEA) and memory in depressed patients. Biological Psychiatry. 35(9). 642–642. 12 indexed citations

Flood, James F., E. Roberts, Mark A. Sherman, Bruce E. Kaplan, & John E. Morley. (1994). Topography of a binding site for small amnestic peptides deduced from structure-activity studies: relation to amnestic effect of amyloid beta protein.. Proceedings of the National Academy of Sciences. 91(1). 380–384. 45 indexed citations

Murphy, Emma J., E. Roberts, & L. A. Horrocks. (1993). Aluminum silicate toxicity in cell cultures. Neuroscience. 55(2). 597–605. 50 indexed citations

Henderson, Victor W., E. Roberts, Cynthia C. Wimer, et al.. (1989). Multicenter trial of naloxone in alzheimer's disease. Annals of Neurology. 25(4). 404–406. 24 indexed citations

Murphy, James R., Shahida Baqar, Richard H. Baker, et al.. (1988). Stage-selective inhibition of rodent malaria by cyclosporine. Antimicrobial Agents and Chemotherapy. 32(4). 462–466. 9 indexed citations

10.

Blum, I, Puiu Nisipeanu, & E. Roberts. (1987). Naloxone in tardive dyskinesia. Psychopharmacology. 93(4). 538–538. 11 indexed citations

11.

Roberts, E. & Diana N. Krause. (1982). gamma-Aminobutyric acid system in cardiovascular and cerebrovascular function.. PubMed. 18(1). 75–81. 8 indexed citations

12.

Svenneby, Gerd & E. Roberts. (1974). Elevated acetylcholine contents in mouse brain after treatment with bicuculline and picrotoxin¹. Journal of Neurochemistry. 23(1). 275–277. 18 indexed citations

13.

Wu, J.‐Y. & E. Roberts. (1974). PROPERTIES OF BRAIN l‐GLUTAMATE DECARBOXYLASE: INHIBITION STUDIES¹. Journal of Neurochemistry. 23(4). 759–767. 167 indexed citations

14.

Tunnicliff, G., et al.. (1972). EFFECTS OF IMIDAZOLEACETIC ACID ON BRAIN AMINO ACIDS AND BODY TEMPERATURE IN MICE¹. Journal of Neurochemistry. 19(9). 2017–2023. 10 indexed citations

15.

Haber, B., Paul Y. Sze, Kengo Kuriyama, & E. Roberts. (1970). GABA as a repressor of L-glutamic acid decarboxylase (GAD) in developing chick embryo optic lobes. Brain Research. 18(3). 545–547. 15 indexed citations

16.

Kuriyama, Kengo, Betty F. Sisken, Jumpei Ito, et al.. (1968). The γ-aminobutyric acid system in the developing chick embryo cerebellum. Brain Research. 11(2). 412–430. 53 indexed citations

17.

Okada, Tadashi & E. Roberts. (1967). Autoradiographic Studies of Localization of Tritiated Methyl N-Carbamyl Maleamate in Ehrlich Ascites Tumor Cells.. Experimental Biology and Medicine. 126(2). 471–474. 1 indexed citations

18.

Weinstein, Harel, Silvio Varon, Donn Muhleman, & E. Roberts. (1965). A carrier-mediated transfer model for the accumulation of 14C γ-aminobutyric acid by subcellular brain particles. Biochemical Pharmacology. 14(3). 273–288. 84 indexed citations

19.

Varon, Silvio, Harel Weinstein, T Kakefuda, & E. Roberts. (1965). Sodium-dependent binding of γ-aminobutyric acid by morphologically characterized subcellular brain particles. Biochemical Pharmacology. 14(8). 1213–1224. 45 indexed citations

20.

Ayengar, Padmasini & E. Roberts. (1960). Incorporation of P32 into the O-Phosphodiester of L-Serine and Ethanolamine in the Turtle.. Experimental Biology and Medicine. 103(4). 811–813. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact